Takeda Biopharmaceuticals India Private Limited, an R&D-driven global biopharmaceutical leader, has received the Great Place To Work® certification in India for March 2023 – March 2024. The company, which was formerly Baxalta Bioscience India Pvt. Ltd., concentrates on four therapeutic areas: Oncology, Rare Genetics and Hematology, Neuroscience, and Gastroenterology (GI).
The Great Place To Work® Institute is a renowned authority on workplace culture, serving organizations in more than 60 countries. Their research emphasizes the importance of strong leadership, consistent employee experience, and sustainable financial performance in creating exceptional
workplaces. Takeda India’s certification highlights its dedication to fostering a culture that values employee well-being, growth, and innovation.
Takeda’s employees collaborate with healthcare partners in approximately 80 countries and regions, focusing on improving patients’ quality of life. The Great Place to Work® certification is a testament to Takeda India’s commitment to creating an employee-focused environment that supports both professional development and the company’s mission and values.
